ASX:CGS Cogstate (CGS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Cogstate Stock (ASX:CGS) 30 days 90 days 365 days Advanced Chart Get Cogstate alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2,002 shsAverage VolumeN/AMarket CapitalizationA$206.30 millionP/E Ratio25.01Dividend Yield10.53%Price TargetN/AConsensus RatingN/A Company Overview Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is also involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its technology and associated services are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The company also provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2023, it had participated in approximately 1,800 academic research studies and 530 industry sponsored clinical trials. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia. Read More Receive CGS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cogstate and its competitors with MarketBeat's FREE daily newsletter. Email Address CGS Stock News HeadlinesWill Weakness in Cogstate Limited's (ASX:CGS) Stock Prove Temporary Given Strong Fundamentals?June 11, 2025 | uk.finance.yahoo.comIncrease in Substantial Shareholder’s Voting Power at Cogstate LimitedJune 11, 2025 | msn.comBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.July 2 at 2:00 AM | Golden Portfolio (Ad)Cogstate (ASX:CGS) Could Become A Multi-BaggerApril 26, 2025 | finance.yahoo.comOne Cogstate Insider Raised Their Stake In The Previous YearApril 9, 2025 | finance.yahoo.comWith 37% ownership, Cogstate Limited (ASX:CGS) insiders have a lot at stakeMarch 27, 2025 | finance.yahoo.comCogstate's (ASX:CGS) investors will be pleased with their stellar 249% return over the last five yearsMarch 10, 2025 | finance.yahoo.comCogstate Limited Just Recorded A 9.5% Revenue Beat: Here's What Analysts ThinkFebruary 21, 2025 | finance.yahoo.comSee More Headlines CGS Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Cogstate own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cogstate investors own include Boston Omaha (BOMN), Fulgent Genetics (FLGT), Adyen (ADYEY), Airbnb (ABNB), American Tower (AMT), Appian (APPN) and Bilibili (BILI). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolASX:CGS CIKN/A Webwww.cogstate.com Phone61 3 9664 1300FaxN/AEmployees158Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$0.05 Trailing P/E Ratio25.01 Forward P/E RatioN/A P/E GrowthN/ANet IncomeA$5.45 million Net Margins12.44% Pretax MarginN/A Return on Equity17.05% Return on Assets6.89% Debt Debt-to-Equity Ratio1.64 Current Ratio3.45 Quick Ratio2.24 Sales & Book Value Annual SalesA$43.43 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow7.79 Book ValueA$0.24 per share Price / BookN/AMiscellaneous Outstanding Shares172,600,000Free FloatN/AMarket CapA$206.30 million OptionableNot Optionable Beta0.14 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (ASX:CGS) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogstate Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cogstate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.